Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05044975 · ClinicalTrials.gov registry record · NA

Improving Sleep in Gynecologic Cancer Survivors

A NA study of Sleep Disturbance and Gynecologic Cancer, sponsored by University of Arizona.

Active
Registry status
NA
Development phase
95
Enrollment target
2
Study locations

NCT05044975 is a NA study of Sleep Disturbance and Gynecologic Cancer that is active but no longer recruiting, run by University of Arizona. The registered enrollment target is 95 participants, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (46% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05044975, a NA study of Sleep Disturbance and Gynecologic Cancer, is active but no longer recruiting, sponsored by University of Arizona.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
95 participants
Enrollment target
2
Study locations

Study Summary

This purpose of this study is to learn about how to provide treatment to gynecologic cancer survivors who have difficulty sleeping.

Interventions

  • BEHAVIORAL Sleep restriction
  • BEHAVIORAL Stimulus control
  • BEHAVIORAL Systematic light exposure

Study Locations (2)

Arizona

  • University of Arizona College of Nursing - Tucson

Illinois

  • Northwestern University Feinberg School of Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2021-10-11
Est. Completion 2026-01-31
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT05044975

The ClinicalTrials.gov registry entry for NCT05044975 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (46% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 3 interventions - of which Sleep restriction is the first listed.

NCT05044975 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Illinois.

Frequently Asked Questions

What is clinical trial NCT05044975 about?

NCT05044975 is a clinical study titled "Improving Sleep in Gynecologic Cancer Survivors". This purpose of this study is to learn about how to provide treatment to gynecologic cancer survivors who have difficulty sleeping.

What is the current status of trial NCT05044975?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2021-10-11. Estimated completion is 2026-01-31.

What conditions does trial NCT05044975 study?

This clinical trial studies the following conditions: Sleep Disturbance, Gynecologic Cancer.

What interventions are being tested in trial NCT05044975?

The interventions under investigation include: Sleep restriction (BEHAVIORAL), Stimulus control (BEHAVIORAL), Systematic light exposure (BEHAVIORAL).

Who is sponsoring clinical trial NCT05044975?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05044975 being conducted?

This trial has 2 study locations across Arizona, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Disturbance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.